Dysregulation of HPA-axis genes in Bipolar Disorder
双相情感障碍中 HPA 轴基因的失调
基本信息
- 批准号:8770987
- 负责人:
- 金额:$ 30.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-11 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdoptionAdverse effectsAlternative SplicingAmygdaloid structureAnimal ModelAutopsyBAG1 geneBehavioralBiological AssayBiologyBipolar DisorderBrainBrain-Derived Neurotrophic FactorCRH geneCandidate Disease GeneClinicalComplexControl GroupsCustomDNADNA MethylationDataDevelopmentDiseaseDrug usageEarly-life traumaEnhancersEnvironmental Risk FactorEpidemiologyEpigenetic ProcessEtiologyEventExonsExposure toFamily StudyFluorescenceFluorescence-Activated Cell SortingFutureGene ExpressionGene ProteinsGenesGeneticGenetic RiskGenomic DNAGlucocorticoidsGoldHeat-Shock Proteins 70Heat-Shock Proteins 90HepatotoxicityHippocampus (Brain)HumanIndividualInstitutesIntronsInvestigationKnowledgeLeadLinkLiteratureManicMeasuresMediatingMental DepressionMental disordersMessenger RNAMetabolic syndromeMethylationMolecularMolecular BiologyMood DisordersMoodsNeuronsPathogenesisPathologyPathway interactionsPatientsPharmaceutical PreparationsPlayPost-Translational Protein ProcessingPrefrontal CortexProcessProtein IsoformsProteinsPublic HealthRNARecording of previous eventsRecurrenceRegulationRelapseRisk FactorsRoleSamplingScanningSignal TransductionSocietiesSorting - Cell MovementStressSymptomsSystemTechniquesTissuesTranscriptTwin Multiple BirthValidationWestern Blottingbiological adaptation to stressbisulfitebrain tissueburden of illnesscohortdisorder controlfightinggene functionhypothalamic-pituitary-adrenal axisimprovedinnovationmRNA Expressionneuropsychiatrynext generation sequencingpreventpublic health relevancepyrosequencingresearch studyresponsetacrolimus binding protein 4
项目摘要
DESCRIPTION (provided by applicant): Bipolar disorder (BP) poses a significant disease burden on society, due to our lack of knowledge of its etiology and mechanism of action of drugs that are used to treat it. Genetic, clinical, and epidemiological evidence suggests the presence of a complex interplay of genetic and environmental risk factors in bipolar disorder. In particular, the HPA-axis system responsible for mounting the "fight-or-flight" response may constitute a significant environmental factor that plays a role in precipitating and exacerbating bipolar disorder symptoms. In order to demonstrate the role of HPA-axis genes in bipolar disorder, we propose to examine in careful detail a set of genes that are: directly involved in mediating the stress-response; implicated in neuropsychiatric disorders or behavioral response to stress; or targeted by or directly influence glucocorticoid-signaling. Our proposal draws strength from preliminary data that show alterations in DNA methylation and expression of the stress-response gene FKBP5 in postmortem brains of bipolar patients. In Aim 1, we will first obtain postmortem brain tissues from control and bipolar samples (N=25 each) that have been well defined in terms of demographic information and drug history. We will process these brain tissues by fluorescence-activated cell sorting (FACS), in order to obtain a more homogeneous neuronal fraction. We will extract genomic DNA from the neuronal fractions, and, using the Methyl-Seq platform, enrich for candidate HPA-axis genes that have been implicated in mood disorders and stress-induced behavioral deficits in animal models. Enriched DNA will then be bisulfite-converted and subjected to next-generation sequencing. DNA methylation data for the candidate HPA-axis genes will be analyzed to identify differentially methylated regions (DMRs) between BP and control tissues. Further, DMRs will be independently verified using pyrosequencing, considered the gold standard for DNA methylation analysis. In Aim 2, we will extract messenger RNA from unsorted tissues to assess expression levels of the candidate HPA-axis genes, using multiple Taqman probes to target isoform-specific exon-intron junctions. We will also perform Western blotting on proteins extracted from the brain tissues to determine the concordance between gene expression and protein levels in bipolar vs. control samples. Results from Aims 1 and 2 will be further analyzed to identify potential DNA methylation-independent mechanisms, alternative splicing, and post-translational modification events specific to bipolar disorder. Taken together, the proposed experiments seek to demonstrate the role that HPA-axis genes may play in bipolar disorder pathology and to provide additional avenues for future investigation into differential regulation of HPA-axis substrates in bipolar disorder.
描述(由申请人提供):双相情感障碍(BP)对社会造成了重大疾病负担,因为我们对其病因和用于治疗它的药物的病因和作用机理缺乏知识。遗传,临床和流行病学证据表明,躁郁症中存在遗传和环境风险因素的复杂相互作用。特别是,负责安装“战斗或飞行”响应的HPA轴系统可能构成一个重要的环境因素,该因素在促进和加剧双相情感障碍症状方面发挥作用。为了证明HPA轴基因在双相情感障碍中的作用,我们建议在仔细详细详细检查一组基因,这些基因直接参与介导应激反应;与神经精神疾病或对压力的行为反应有关;或由或直接影响糖皮质激素信号。我们的建议从初步数据中获取强度,这些数据显示了双极患者后大脑中DNA甲基化和应力反应基因FKBP5的表达改变。在AIM 1中,我们将首先从对照和双极样品(n = 25)中获得验尸后脑组织,这些样品已在人口统计学信息和药物病史方面得到很好的定义。我们将通过荧光激活的细胞分选(FACS)来处理这些脑组织,以获得更均匀的神经元分数。我们将从神经元分数中提取基因组DNA,并使用甲基序列平台富含与情绪障碍和动物模型中压力诱导的行为缺陷有关的候选HPA轴基因。然后将富集的DNA转换并进行下一代测序。将分析候选HPA轴基因的DNA甲基化数据,以鉴定BP和对照组织之间的差异甲基化区域(DMR)。此外,DMR将使用焦磷酸测序(被认为是DNA甲基化分析的金标准)独立验证。在AIM 2中,我们将使用多个TAQMAN探针靶向同工型特异性外显子 - 内隆连接点,从未分类的组织中提取信使RNA,以评估候选HPA轴基因的表达水平。我们还将对从脑组织提取的蛋白质进行蛋白质印迹,以确定双极与对照样品中基因表达与蛋白水平之间的一致性。目标1和2的结果将进一步分析,以确定潜在的DNA甲基化机制,替代剪接以及针对双相情感障碍的翻译后修饰事件。综上所述,拟议的实验试图证明HPA轴基因在双相情感障碍病理学中可能起的作用,并为将来研究双相情感障碍中HPA轴底物的差异调节提供了其他途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard S Lee其他文献
IDENTIFICATION OF NOVEL URINARY BIOMARKERS OF RENAL OBSTRUCTION USING TEMPORAL QUANTITATIVE PROTEOMICS
- DOI:
10.1016/s0022-5347(09)60717-5 - 发表时间:
2009-04-01 - 期刊:
- 影响因子:
- 作者:
Alireza Vaezzadeh;Andrew C Briscoe;Lee Dicker;Oliver Hofman;Winston Hide;Hanno Steen;Richard S Lee - 通讯作者:
Richard S Lee
Epigenetic Approaches to Behavioral Neuroscience
行为神经科学的表观遗传学方法
- DOI:
10.1016/b978-0-12-819641-0.00097-9 - 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Richard S Lee - 通讯作者:
Richard S Lee
Glucocorticoid-Dependent Epigenetic Regulation of Fkbp5
- DOI:
10.1007/978-3-319-24493-8_4 - 发表时间:
2016 - 期刊:
- 影响因子:0
- 作者:
Richard S Lee - 通讯作者:
Richard S Lee
Richard S Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Augmenting Pharmacogenetics with Multi-Omics Data and Techniques to Predict Adverse Drug Reactions to NSAIDs
利用多组学数据和技术增强药物遗传学,预测 NSAID 的药物不良反应
- 批准号:
10748642 - 财政年份:2023
- 资助金额:
$ 30.22万 - 项目类别:
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options
药物基因组学工作流程:识别生物标志物和治疗方案
- 批准号:
10819933 - 财政年份:2023
- 资助金额:
$ 30.22万 - 项目类别:
Intersectional Stigma Reduction for Tajik Migrants Who Inject Drugs
减少注射毒品的塔吉克移民的跨部门耻辱
- 批准号:
10755435 - 财政年份:2023
- 资助金额:
$ 30.22万 - 项目类别:
Identifying Safe Stimulant Prescribing Practices to Protect Patients, Inform Key Program Initiatives, and Assist Providers
确定安全的兴奋剂处方实践以保护患者、为关键计划举措提供信息并协助提供者
- 批准号:
10534426 - 财政年份:2023
- 资助金额:
$ 30.22万 - 项目类别:
Walking Exercise Sustainability Through Telehealth for Veterans with Lower-LimbAmputation
通过远程医疗为下肢截肢退伍军人提供步行锻炼的可持续性
- 批准号:
10534859 - 财政年份:2022
- 资助金额:
$ 30.22万 - 项目类别: